Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Simoons

Showing results (201-210 of 338) with videos related to

Pageof 34
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 1, 1995
Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, The NetherlandsJ K Bleeker, M L Simoons, R A Erdman, et al.
The American Journal of Cardiology|February 1, 1985
Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise-redistribution thallium scintigraphyW Wijns, P W Serruys, J H Reiber, et al.
Acta Cardiologica. Supplementum|January 1, 1981
Computer analysis of the exercise ECG: new aspectsP Block, J Cornelis, E Nyssen, et al.
European Heart Journal|October 26, 1999
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trialM van den Brand, G J Laarman, P G Steg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1983
Clinical validation of fully automated computation of ejection fraction from gated equilibrium blood-pool scintigramsJ H Reiber, S P Lie, M L Simoons, et al.
Journal of the American College of Cardiology|January 1, 1991
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study GroupA E Arnold, P W Serruys, W Rutsch, et al.
Heart (British Cardiac Society)|May 12, 2011
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndromeR M Oemrawsingh, T Lenderink, K M Akkerhuis, et al.
Journal of the American College of Cardiology|September 1, 1989
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PAA E Arnold, R W Brower, D Collen, et al.
European Heart Journal|March 1, 1995
Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposalsE W Grijseels, J W Deckers, A W Hoes, et al.
Cardiovascular Drugs and Therapy|July 28, 2007
ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trialM L Bots, W J Remme, T F Lüscher, et al.
Pageof 34

Showing results (201-210 of 338) with videos related to

Sort By:
Pageof 34
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 1, 1995
Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, The NetherlandsJ K Bleeker, M L Simoons, R A Erdman, et al.
The American Journal of Cardiology|February 1, 1985
Early detection of restenosis after successful percutaneous transluminal coronary angioplasty by exercise-redistribution thallium scintigraphyW Wijns, P W Serruys, J H Reiber, et al.
Acta Cardiologica. Supplementum|January 1, 1981
Computer analysis of the exercise ECG: new aspectsP Block, J Cornelis, E Nyssen, et al.
European Heart Journal|October 26, 1999
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trialM van den Brand, G J Laarman, P G Steg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1983
Clinical validation of fully automated computation of ejection fraction from gated equilibrium blood-pool scintigramsJ H Reiber, S P Lie, M L Simoons, et al.
Journal of the American College of Cardiology|January 1, 1991
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study GroupA E Arnold, P W Serruys, W Rutsch, et al.
Heart (British Cardiac Society)|May 12, 2011
Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndromeR M Oemrawsingh, T Lenderink, K M Akkerhuis, et al.
Journal of the American College of Cardiology|September 1, 1989
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PAA E Arnold, R W Brower, D Collen, et al.
European Heart Journal|March 1, 1995
Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposalsE W Grijseels, J W Deckers, A W Hoes, et al.
Cardiovascular Drugs and Therapy|July 28, 2007
ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trialM L Bots, W J Remme, T F Lüscher, et al.
Pageof 34